Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > NOLs

<< Previous

Bullboard Posts

Next >>

Comment by snootchybootchyon Jun 10, 2016 9:16pm

54 Views

Post# 24956641

RE:RE:NOLs

LG2264 wrote: I may be missing something, which is entirely possible, but what revenues are you referring to. The only revenue they have received in the last couple of years have been from termination fees.

No, QLT does not appear to have any revenue-generating assets. What I meant was that Aralez can take the cash and buy revenue-generating assests and use the NOLs to offset the taxes on any profits generated by those acquired assets.

Over-levered spec pharma companies (i.e., Valeant) are looking to sell assets to reduce debt and Aralez can take advantage with QLT's cash.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity